Carmila: Termination of Liquidity Contract With BNP Paribas Arbitrage and New Liquidity Contract With Kepler Cheuvreux
November 10 2023 - 2:17PM
Business Wire
Regulatory News:
On 10 November 2023, the liquidity contract between BNP Paribas
Arbitrage and Carmila (Paris:CARM) dated 28 June 2019 was
terminated. On 3 November 2023, Carmila and Kepler Cheuvreux signed
a liquidity contract concerning the liquidity of Carmila shares
(ISIN : FR0010828137), (the Shares) admitted for trading on
Euronext Paris (the Contract), which will begin on 13 November
2023.
The implementation of the Contract will be carried out in
accordance with the legal provisions in force, and more
particularly the provisions of Regulation (EU) no. 596/2014 of the
European Parliament and of the Council of 16 April 2014 on market
abuse (MAR), of Commission Delegated Regulation (EU) 2016/908 of 26
February 2016 supplementing Regulation (EU) No 596/2014 of European
Parliament and of the Council by regulatory technical standards
concerning the criteria, procedure and requirements for the
establishment of an admitted market practice and the requirements
for the maintenance, withdrawal or modification of conditions of
admission, and articles L. 225-209 et seq. of the Commercial Code,
as well as AMF decision no. 2018-01 of July 2, 2018, applicable
from January 1, 2019.
The resources made available for the liquidity agreement are as
follows:
- 971 454.65 euros
- 124 528 Carmila shares
Performance of the Contract will be suspended under the
conditions described in article 5 of AMF decision no. 2018-01 of
July 2, 2018.
INVESTOR AGENDA 13 February 2024 (after market
close): 2023 annual results 14 February 2024: Annual
results presentation 17 April 2024 (after market close):
Financial information for the first quarter 2024 24 April
2024: Annual Shareholder Meeting 24 July 2024 (after market
close): First half 2024 results 25 July 2024: First half
2024 results presentation 17 October 2024 (after market
close): Financial information for the third quarter 2024
ABOUT CARMILA
The third-largest listed owner of retail property in Europe,
Carmila was founded by Carrefour and institutional investors to
enhance the value of shopping centres adjoining Carrefour
hypermarkets in France, Spain and Italy. At 30 June 2023, its
portfolio was valued at €6.0 billion and made up of 202 shopping
centres, with leading positions in their catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”).
Carmila has been a member of the SBF 120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Financial Press Releases” section of Carmila’s Finance webpage:
https://www.carmila.com/en/finance/financial-press-releases
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231110102413/en/
INVESTORS AND ANALYSTS Jonathan Kirk – Head of Investor
Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
Historical Stock Chart
From Apr 2024 to May 2024
Carisma Therapeutics (NASDAQ:CARM)
Historical Stock Chart
From May 2023 to May 2024